Alpha Teknova (TKNO) Depreciation & Amortization (CF) (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Depreciation & Amortization (CF) of $1.6 million for Q1 2026, little changed year-over-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $1.6 million in Q4 2025.
Alpha Teknova (TKNO) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) changed 0.25% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.3 million (down 2.82% YoY), while the FY2025 annual figure was $6.3 million, down 3.59% from the prior year.
- Depreciation & Amortization (CF) held at $1.6 million in Q1 2026 per TKNO's latest filing, from $1.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q3 2024 and bottomed at $729000.0 in Q3 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.4 million across 5 years, with a median of $1.6 million in 2025.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 122.5% — and 2025, when it retreated 4.79%.
- Alpha Teknova's Depreciation & Amortization (CF) stood at $893000.0 in 2022, then soared by 80.4% to $1.6 million in 2023, then climbed by 2.11% to $1.6 million in 2024, then declined by 3.89% to $1.6 million in 2025, then slipped by 0.32% to $1.6 million in 2026.
- Business Quant data shows TKNO's Depreciation & Amortization (CF) at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |